WallStSmart
KRYS

Krystal Biotech Inc

NASDAQ: KRYS · HEALTHCARE · BIOTECHNOLOGY

$259.95
-3.46% today

Updated 2026-04-29

Market cap
$7.65B
P/E ratio
38.06
P/S ratio
19.66x
EPS (TTM)
$6.83
Dividend yield
52W range
$123 – $298
Volume
0.3M

Krystal Biotech Inc (KRYS) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2016201720182019202020212022202320242025
Revenue$0.00$0.00$1.03M$0.00$0.00$0.00$0.00$50.70M$290.51M$389.13M
Revenue growth (YoY)-100.0%+473.0%+33.9%
Cost of revenue$2000.00$23000.00$141000.00$974000.00$1.85M$2.77M$4.05M$3.09M$20.06M$28.77M
Gross profit$-2000.00$-23000.00$886000.00$-974000.00$-1.85M$-2.77M$-4.05M$47.60M$270.45M$360.36M
Gross margin86.3%93.9%93.1%92.6%
R&D$741000.00$3.21M$7.76M$15.62M$17.94M$27.88M$42.46M$46.43M$53.57M$58.05M
SG&A$402000.00$1.56M$4.16M$6.46M$15.06M$40.39M$77.73M$98.40M$113.69M$146.74M
Operating income$-1.14M$-4.77M$-11.92M$-22.08M$-33.00M$-68.28M$-145.20M$-109.73M$65.69M$161.29M
Operating margin-1160.3%-216.4%22.6%41.5%
EBITDA$-1.14M$-4.63M$-10.75M$-18.11M$-30.32M$-66.23M$-116.81M$-91.32M$109.91M$167.85M
EBITDA margin-1046.5%-180.1%37.8%43.1%
EBIT$-1.14M$-4.66M$-10.89M$-19.09M$-32.17M$-68.08M$-120.20M$-97.23M$103.19M$161.29M
Interest expense$7000.00$3.15M$1.03M$0.00$832000.00$1.49M$5.22M$0.00
Income tax$0.00$0.00$-20141.00$576140.00$1.64M$2.73M$34.05M$1.97M$6.20M
Effective tax rate0.0%0.0%0.2%-3.1%-5.4%-4.1%-32.1%15.2%6.5%0.0%
Net income$-1.15M$-7.92M$-10.89M$-19.09M$-32.17M$-69.57M$-139.97M$10.93M$89.16M$204.83M
Net income growth (YoY)-588.7%-37.5%-75.3%-68.5%-116.3%-101.2%+107.8%+715.6%+129.7%
Profit margin-1060.3%21.6%30.7%52.6%